본문 바로가기
KERD
논문KCI 등재

제약산업의 경영전략, 경영성과에 의약품관련정책이 미치는 영향에 관한 연구

Study on Medicine Related Policies for Management Strategies and Performances of the Pharmaceutical Industry

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

초록

Objectives : The aim of this study was to investigate the effect of various Republic of Korea policies, including the medicine cost rationalization policy implemented By investigating the management strategy/performance changes of the industry caused by such policies. Methods : Pharmaceutical companies listed on the national stock exchange and the KOSDAQ were examined for 10 years from 2004 to 2013. Their financial statements were collected and market changes before and after drug price policy implementations were compared. Results : From the result of this research, among the medicine related policies, the drug price rationalization policy was found to have a significant effect on business management strategies in terms of safety, profitability and growth potential after its implementation. After the drug pricing transparency policy was implemented, management strategies were affected significantly in terms of safety and profitability. Conclusions : As a result, all of the medicine related policies were found to have regulatory effects. Based on these findings, implications, research limitations and future study plans are presented.

Abstract

Objectives : The aim of this study was to investigate the effect of various Republic of Korea policies, including the medicine cost rationalization policy implemented By investigating the management strategy/performance changes of the industry caused by such policies. Methods : Pharmaceutical companies listed on the national stock exchange and the KOSDAQ were examined for 10 years from 2004 to 2013. Their financial statements were collected and market changes before and after drug price policy implementations were compared. Results : From the result of this research, among the medicine related policies, the drug price rationalization policy was found to have a significant effect on business management strategies in terms of safety, profitability and growth potential after its implementation. After the drug pricing transparency policy was implemented, management strategies were affected significantly in terms of safety and profitability. Conclusions : As a result, all of the medicine related policies were found to have regulatory effects. Based on these findings, implications, research limitations and future study plans are presented.

참고문헌 (21)

  1. Y. J. Kwon, "A study on pharmaceutical item distribution and its improvement in Korean market", 석사, pp.2009
  2. S. M. Kwon, "Strategy hospital for drug-related policy and institutional changes", J of Hospital management, 1999(1), pp.40~60 (1999)
  3. K. J. Cho, "Policy challenges and the impact of price cuts in the domestic pharmaceutical industry", KDB Monthly Bulletin, 717, pp.52~67 (2011)
  4. G. Y. Oh, "Pharmaceuticals welfare changes over the FTA negotiations IPR", pp.57~58 (2010), Jipmoon
  5. K. M. Lee, "A study on interrelationship among company competence, business strategy, and performance : the case of Korean pharmaceutical companies", 박사, pp.2007
  6. 허재헌, "보험의약품 가격 규제와 기업행동: 생산활동을 중심으로", 보건경제와 정책연구, 17(3), pp.101~126 (2011), 한국보건경제정책학회
  7. Department of Health and Human Services Press, "Health Insurance drug price rationalization measures implemented, 2006. 12. 27", ~ (2006)
  8. Department of Health and Human Services Press, "The actual transaction type drug market enforcement, 2010. 09. 30", ~ (2010)
  9. Department of Health and Human Services Press, "Rebate SsangbeolJae enforcement, 2010. 11. 26", ~ (2010)
  10. Department of Health and Human Services Press, "The new administration announced price cuts notice, 2011. 10. 31", ~ (2011)
  11. Department of Health and Human Services Press, "Pharmaceutical Industry Competitiveness Plan, 2012. 01. 06", ~ (2012)
  12. S.H. Lee, "A study on feasibility of pharmaceutical rebate dual punishment : forcus on the allegations for constitutionality", 석사, pp.2014
  13. H. W. Yang, "A Critical Review on the rebate ssangbeol", 박사, pp.2012
  14. 조덕영, "종합병원의 경영성과에 영향을 미치는 요인에 관한 연구", 보건의료산업학회지, 6(4), pp.111~120 (2012), 보건의료산업학회
  15. I. S. Kang, "A study on the structural relationship analysis of management environment, strategy, firm structure and performance in hotel industry", 박사, pp.2002
  16. D. W. Lee, "A Study on the Effect of Company Growth before and after the Rebate Regulations in the Pharmaceutical Industry", 박사, pp.2012
  17. H. Y. Ju, "Study on impact of 'Drug Price Reform and Plan for Advancement of Pharmaceutical industry' Policy : A Case Study of Major Pharmaceutical Companies", 석사, pp.2015
  18. H. W. Choi, "Study on Measures to Fostering of the Pharmaceutical Industry", 석사, pp.2012
  19. M. E. Porter, "Competitive Strategy:Techniques for Analyzing Industries and Competitors", pp.126~151 (1980), Free Press
  20. S. W. Pyeon, "The effects of pharmaceutical policies and influential factors for pharmaceutical industry", 박사, pp.2012
  21. Y. H. Kim, "Analysis of Factors Affecting Profitability of General Hospital in Kyung-in Region", J of Korean Society of Hospital Management, 4(1), pp.41~65 (1999)

관련 논문AI추천

이 간행물의 다른 논문 (14건)